Sabatini C, Kim J H, Ortiz Alias P
Oper Dent. 2014 May-Jun;39(3):283-90. doi: 10.2341/13-131-LR. Epub 2013 Aug 12.
Inhibition of endogenous dentin matrix metalloproteinases (MMPs) by benzalkonium chloride (BAC) decreases collagen solubilization and may help improve resin-dentin bond stability.
This study evaluated the resin-dentin bond stability of experimental adhesive blends containing BAC and the stability of dentin matrices by assessing the mass loss and collagen solubilization from dentin beams pretreated with BAC.
Twenty-five healthy molars were used for the bond strength evaluation of a two-step etch-and-rinse adhesive (Adper Single Bond Plus, SB) modified with BAC or not. The following groups were tested: 1) SB with no inhibitor (control); 2) topical 2.0% chlorhexidine + SB; 3) 1.0% BAC etchant + SB; 4) 0.5% BAC-SB; and 5) 1.0% BAC-SB. Microtensile bond strength (μTBS) and failure mode distribution under standard error of the mean were evaluated after 24 hours and six months of storage in artificial saliva (AS). A two-way analysis of variance and Tukey test with a significance level of p<0.05 was used for data analysis. In addition, 30 completely demineralized dentin beams from human molars were either dipped in deionized water (DW, control) or dipped in 0.5% and 1.0% BAC for 60 seconds, and then incubated in AS. Collagen solubilization was assessed by evaluating the dry mass loss and quantifying the amount of hydroxyproline (HYP) released from hydrolyzed specimens after four weeks of incubation.
The control group demonstrated lower μTBS than some of the experimental groups containing BAC at 24 hours and six months (p<0.05). When BAC was incorporated into the adhesive blend in concentrations of 0.5% and 1.0%, no reduction in dentin bond strength was observed after six months (p<0.05). Less mass loss and HYP release was seen for dentin matrices pretreated with BAC relative to the control pretreated with DW (p<0.05).
This in vitro study demonstrates that BAC contributes to the preservation of resin-dentin bonds by reducing collagen degradation.
苯扎氯铵(BAC)对内源性牙本质基质金属蛋白酶(MMPs)的抑制作用可减少胶原蛋白的溶解,并可能有助于提高树脂-牙本质粘结稳定性。
本研究通过评估经BAC预处理的牙本质梁的质量损失和胶原蛋白溶解情况,来评价含BAC的实验性粘合剂混合物的树脂-牙本质粘结稳定性以及牙本质基质的稳定性。
使用25颗健康磨牙对未添加或添加BAC的两步蚀刻冲洗粘合剂(Adper Single Bond Plus,SB)进行粘结强度评估。测试以下几组:1)无抑制剂的SB(对照组);2)局部应用2.0%氯己定+SB;3)1.0%BAC蚀刻剂+SB;4)0.5%BAC-SB;5)1.0%BAC-SB。在人工唾液(AS)中储存24小时和6个月后,评估微拉伸粘结强度(μTBS)和平均标准误差下的失效模式分布。采用显著性水平为p<0.05的双向方差分析和Tukey检验进行数据分析。此外,将30根来自人类磨牙的完全脱矿牙本质梁要么浸入去离子水(DW,对照组)中,要么浸入0.5%和1.0%BAC中60秒,然后在AS中孵育。通过评估干质量损失并对孵育四周后水解标本释放的羟脯氨酸(HYP)量进行定量,来评估胶原蛋白溶解情况。
在24小时和6个月时,对照组的μTBS低于一些含BAC的实验组(p<0.05)。当以0.5%和1.0%的浓度将BAC加入粘合剂混合物中时,6个月后未观察到牙本质粘结强度降低(p<0.05)。相对于用DW预处理的对照组,用BAC预处理的牙本质基质的质量损失和HYP释放较少(p<0.05)。
这项体外研究表明,BAC通过减少胶原蛋白降解有助于维持树脂-牙本质粘结。